Assignee
SIRIUS THERAPEUTICS INC
US·3 granted patents·7 pending applications·4 citations·filing 2017–2025
Top patents by PatentIndex Score
10 records- 0181US11981703B2Polynucleotide constructsSIRIUS THERAPEUTICS INC·Filed 2017·Granted May 14, 2024·2 cites·13 claims
- 0281US11597744B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·2 cites·20 claims
- 0374US2024247025A1Polynucleotide constructsSIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0473US12269839B2Chiral phosphoramidite auxiliaries and methods of their useSIRIUS THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·13 claims
- 0569US2024271143A1Polynucleic acid molecules targeting pcsk9 and uses thereofSIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0658US2025333738A1Polynucleic acid molecules for inhibiting expression of angptl3, pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0756US2025361508A1Polynucleic acid molecules targeting agt and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0850US2025250573A1Polynucleic acid molecules for inhibiting expression of fxi, pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0948US2025188465A1Polynucleic acid molecules targeting apoc3 and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1048US2025188464A1Polynucleic acid molecules for inhibiting expression of lp(a), pharmaceutical compositions, and uses thereofSIRIUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →